Adjusted, Significant Associations between Individual, Residency, and Current Practice Characteristics with Preparedness to Provide and Current Provision of Buprenorphine Treatment
Characteristic | Prepared to Provide Buprenorphine Treatment in Residency OR (95% CI) | Currently Providing Buprenorphine Treatment OR (95% CI) |
---|---|---|
Prepared to provide buprenorphinea | … | 13.50 (7.59-24.03) |
Engaged in researchb | 1.69 (1.05-2.72) | 2.17 (1.28-3.67) |
Residency geographic region | ||
Northeastc | Reference | … |
Southc | 0.30 (0.15-0.61) | … |
Midwestc | 0.28 (0.13-0.58) | … |
Westc | 0.52 (0.24-1.11) | … |
Current practice geographic region | ||
Northeastd | … | Reference |
Southd | … | 0.50 (0.25-0.99) |
Midwestd | … | 0.37 (0.16-0.84) |
Westd | … | 0.87 (0.45-1.69) |
Current practice in FQHCd | … | 2.51 (1.45-4.33) |
Current practice size | ||
Solo practiced,e | … | Reference |
2-5 physiciansd,e | … | … |
6-20 physiciansd,e | … | … |
>20 physiciansd,e | … | … |
FQHC = federally qualified health center; OR = odds ratio.
↵a Preparedness is self-reported as prepared in residency to provide buprenorphine treatment.
↵b Research is self-reported in the survey as engagement in research or practice-based research network activities.
↵c Not included in currently providing treatment analysis.
↵d Not included in prepared to provide analysis.
↵e Not significant in currently providing treatment multivariate analysis.